Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric Disorders

E-ISSN： 1873-4294|16|29|3527-3535

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.29, 2016-12, pp. : 3527-3535

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peri-operative Decreased cAMP Levels in Long-term Alcoholic Patients

By Schoenfeld H Franke R von Heymann C Doepfmer UR Blaicher AM Ziemer S Spies C

The Journal of International Medical Research, Vol. 34, Iss. 5, 2006-09 ,pp. : 445-455

Field House Publishing

Access to resources Recommend Favorite

Regulators of Platelet cAMP Levels: Clinical and Therapeutic Implications

Current Medicinal Chemistry, Vol. 17, Iss. 26, 2010-09 ,pp. : 2897-2905

Bentham Science Publishers

Access to resources Recommend Favorite

-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders

By Hayashi T. Su T-P.

CNS Drugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 269-284

Adis International

Access to resources Recommend Favorite

Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes

By Nishikimi T. Horio T. Yoshihara F. Nagaya N. Matsuo H. Kangawa K.

European Journal of Pharmacology, Vol. 353, Iss. 2, 1998-07 ,pp. : 337-344

Elsevier

Access to resources Recommend Favorite

Transforming growth factor- 1 inhibits the growth of primary adult rat hepatocyte cultures by increasing cAMP levels

By Kimura M. Ogihara M.

European Journal of Pharmacology, Vol. 386, Iss. 2, 1999-12 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite